Moxetumomab pasudotox and Pegfilgrastim Subcutaneous
Determining the interaction of Moxetumomab pasudotox and Pegfilgrastim Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: pegfilgrastim
Brand name: Fulphila, Neulasta, Neulasta Onpro Kit, Udenyca, Neulasta Delivery Kit
Synonyms: Pegfilgrastim
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Pegfilgrastim-cbqv
- Moxetumomab pasudotox-Pegfilgrastim-jmdb
- Moxetumomab pasudotox-Pegfilgrastim-jmdb Subcutaneous
- Moxetumomab pasudotox-Peginesatide Injection
- Moxetumomab pasudotox-Peginterferon alfa-2a
- Moxetumomab pasudotox-Peginterferon alfa-2a Subcutaneous
- Pegfilgrastim Subcutaneous-Moxetumomab Pasudotox-tdfk
- Pegfilgrastim Subcutaneous-Moxetumomab pasudotox-tdfk Intravenous
- Pegfilgrastim Subcutaneous-Moxifloxacin
- Pegfilgrastim Subcutaneous-Moxifloxacin (Systemic)
- Pegfilgrastim Subcutaneous-Moxifloxacin Hydrochloride
- Pegfilgrastim Subcutaneous-Moxifloxacin Injection